Avacta and Adeptrix will collaborate to develop and manufacture an Affimer-based BAMS coronavirus antigen test that will provide clinicians with a significant expansion of the available testing capacity for COVID-19 infection in hospitals. Adeptrix’s novel BAMS platform combines enrichment of the sample to improve sensitivity with the power of mass-spectrometry to improve specificity...
From sourdough starters to biotechnological bugs, micro-organisms make the products society wants and needs. The new European Green Deal is dependent on engineered microbes to make biochemicals to replace oil and synthetic chemicals as building blocks for consumer goods. Microbes can be repurposed to make useful products but one limitation is that many microbes are not able...
Merck and Baylor College of Medicine have announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19, designed to accelerate transition to Phase 1 clinical trials. “Vaccine manufacturing is extremely complicated, so we are collaborating on a process development approach to accelerate manufacturing of Baylor’s Covid-19 vaccine candidate...
By Professor Georgina Ellison-Hughes, Dr Rocio Martinez-Nunez and Dr Rui Ribeiro Galao, Faculty of Life Sciences & Medicine, King’s College London. With promises of antibody tests being rolled out in the next few days to NHS and care staff in England, and retailers told not to send home-testing kits as their accuracy is questioned, it is timely to consider what we do and don’t know about these tests....
Agilent Technologies Inc. announces that biotech startup Trilogy Sciences has been awarded an Agilent Golden Ticket at LabCentral, a leading biotech innovation hub based in Cambridge, Massachusetts. LabCentral is a shared laboratory space designed as a launchpad for high-potential life sciences and biotech startups. The Golden Ticket provides funding of one lab bench space for a year...
Jian-Wei Pan, Professor at the University of Science and Technology of China, in Hefei, is the winner of the prestigious ZEISS Research Award 2020. He is one of the world's leading researchers in the field of quantum technology. One of the most remarkable results of Jian-Wei Pan's research is the distribution of entangled photons over a distance of 1,200 km, by far the longest distance ever reached....
Postnova Analytics reports how its latest generation of Asymmetrical Flow Field Flow Fractionation (AF4) systems are providing labs worldwide with a uniquely powerful technique to characterize and quantitate virus and virus-like particles. Virus and virus-like particles are widely used in the healthcare industry for vaccination via immune response stimulation....
To capture the importance of this initiative, and in anticipation of the grand opening of the Ellison Institute’s new building, Olympus has created a video, highlighting the relationship between imaging analysis tools and precision cancer medicine. One focus of the partnership is encouraging projects that engage translational oncology and precision anti-cancer drug screening...
Conversations on face mask efficacy and supply for frontline workers and the general public have been heated topics amid the Covid-19 pandemic. As the first in a series of monthly “Pandemic Response Catalyst Conversations,” three leading scientific experts will provide facts and data-driven insights on the current global mask supply, filtration properties of masks and a preview of technological innovations improving masks...
Scientists have discovered a malaria transmission-blocking microbe, making an important stride in the fight against the disease. The disease kills around 400,000 people each year and imposes a huge burden on Africa. The World Health Organisation (WHO) recently stressed the need to continue the efforts against malaria, despite the necessary focus on COVID-19...
The sensitivity of Beckman Coulter Life Sciences’ CytoFLEX Flow Cytometer is underpinning a pioneering multinational research initiative. This is designed to transform the lives of those suffering from a disfiguring and potentially life threatening parasitic disease. The research team has just secured a grant of eight million Euros from the European & Developing Countries Clinical Trials Partnership...
Dr Laura Moro-Martin, freelance medical writer at Kolabtree, the freelance platform for scientists, explores the effects of COVID-19 on maternal health. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to escalate worldwide, with Europe and the USA now the epicentres of the pandemic. As of May 1, there are over three million declared cases and almost 240,000 deaths globally, with many countries undergoing community transmission....
HALIX B.V. has joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine (ChAdOx1 nCoV-19), being developed by the University’s Jenner Institute. This GMP manufacturing scale-up is taking place alongside early phase clinical trials. The trials are crucial in testing whether the vaccine is proven to be effective....
HORIBA UK Ltd, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help haematology laboratories simplify and expedite the performance of blood and body fluid differentials. CellaVision’s digital cell morphology systems can now be integrated with HORIBA’s HELO automated haematology platform, enabling unique two-way data flow and rapid validation of cell morphology results....
The Lighthouse Laboratory in Glasgow – a major new COVID-19 testing facility based in Scotland – is now operational. The Lighthouse Lab, which officially started testing samples for COVID-19 this week, is part of what will be the biggest network of diagnostic testing facilities in British history, alongside other Lighthouse Lab sites in Milton Keynes and Alderley Park, which were opened in recent days....
The Wyss Institute for Biologically Inspired Engineering at Harvard University and Cytosurge AG, a company manufacturing unique high-precision nanotechnology instruments, have announced that they will collaboratively investigate CRISPR-based approaches to more effectively introduce multiple edits into the genome of single cells, while minimizing CRISPR-related toxicity. This capability could become instrumental in driving forward diverse large-scale efforts such as...
Data scientists from UK-headquartered AI precision medicine company, PrecisionLife, have used the Company’s proprietary AI enabled precision medicine platform to identify 59 repurposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from severe COVID-19. The new study, released on Biorxiv sought to identify genetic risk factors for sepsis especially in the context of COVID-19, and to use these insights to identify existing....
A group of researchers based at Rothamsted Research have responded to a request from the White House, Microsoft, Mark Zuckerberg and others to find a way to rapidly sift through the mountain of COVID-19 scientific data. Taking time off from their own research, the Rothamsted team repurposed a tool they had originally developed to help crop scientists, to provide medical researchers with quick and intuitive access to all documented linkages between genes, medicines, and the virus....
For use in advanced medical research into inflammation, oncology and nephritis the 7T PET-MR imaging system from MR Solutions provides a combination of PET and MRI images either simultaneously or separately. This ground breaking combination technology allows researchers to have superior soft tissue contrast and molecular imaging together.
U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company) Anti-SARS-CoV-2 ELISA (IgG) serology test. Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA for the detection of antibodies of the immunoglobulin class G....
Analysis work from the MRC-University of Glasgow Centre for Virus Research provides evidence that SARS-CoV-2, the virus that causes COVID-19, has not mutated into different types. Recent research had suggested that more than one type of SARS-CoV-2 was now circulating in the pandemic, with one strain being more aggressive and causing more serious illness than the other. Now, using analysis of SARS-CoV-2 virus samples from the pandemic, scientists have been able to show that only one type of the virus is currently circulating....
To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia and industry groups battling the spread of the pandemic globally. Under the program, the company will provide 50 units of the Ion Torrent Genexus System at a subsidized price to support global collaborative COVID-19 research....
Avacta and Adeptrix will collaborate to develop and manufacture an Affimer-based BAMS coronavirus antigen test that will provide clinicians with a significant expansion of the available testing capacity for COVID-19 infection in hospitals. Adeptrix’s novel BAMS platform combines enrichment of the sample to improve sensitivity with the power of mass-spectrometry to improve specificity...
From sourdough starters to biotechnological bugs, micro-organisms make the products society wants and needs. The new European Green Deal is dependent on engineered microbes to make biochemicals to replace oil and synthetic chemicals as building blocks for consumer goods. Microbes can be repurposed to make useful products but one limitation is that many microbes are not able...
Merck and Baylor College of Medicine have announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19, designed to accelerate transition to Phase 1 clinical trials. “Vaccine manufacturing is extremely complicated, so we are collaborating on a process development approach to accelerate manufacturing of Baylor’s Covid-19 vaccine candidate...
By Professor Georgina Ellison-Hughes, Dr Rocio Martinez-Nunez and Dr Rui Ribeiro Galao, Faculty of Life Sciences & Medicine, King’s College London. With promises of antibody tests being rolled out in the next few days to NHS and care staff in England, and retailers told not to send home-testing kits as their accuracy is questioned, it is timely to consider what we do and don’t know about these tests....
Agilent Technologies Inc. announces that biotech startup Trilogy Sciences has been awarded an Agilent Golden Ticket at LabCentral, a leading biotech innovation hub based in Cambridge, Massachusetts. LabCentral is a shared laboratory space designed as a launchpad for high-potential life sciences and biotech startups. The Golden Ticket provides funding of one lab bench space for a year...
Jian-Wei Pan, Professor at the University of Science and Technology of China, in Hefei, is the winner of the prestigious ZEISS Research Award 2020. He is one of the world's leading researchers in the field of quantum technology. One of the most remarkable results of Jian-Wei Pan's research is the distribution of entangled photons over a distance of 1,200 km, by far the longest distance ever reached....
Postnova Analytics reports how its latest generation of Asymmetrical Flow Field Flow Fractionation (AF4) systems are providing labs worldwide with a uniquely powerful technique to characterize and quantitate virus and virus-like particles. Virus and virus-like particles are widely used in the healthcare industry for vaccination via immune response stimulation....
To capture the importance of this initiative, and in anticipation of the grand opening of the Ellison Institute’s new building, Olympus has created a video, highlighting the relationship between imaging analysis tools and precision cancer medicine. One focus of the partnership is encouraging projects that engage translational oncology and precision anti-cancer drug screening...
Conversations on face mask efficacy and supply for frontline workers and the general public have been heated topics amid the Covid-19 pandemic. As the first in a series of monthly “Pandemic Response Catalyst Conversations,” three leading scientific experts will provide facts and data-driven insights on the current global mask supply, filtration properties of masks and a preview of technological innovations improving masks...
Scientists have discovered a malaria transmission-blocking microbe, making an important stride in the fight against the disease. The disease kills around 400,000 people each year and imposes a huge burden on Africa. The World Health Organisation (WHO) recently stressed the need to continue the efforts against malaria, despite the necessary focus on COVID-19...
The sensitivity of Beckman Coulter Life Sciences’ CytoFLEX Flow Cytometer is underpinning a pioneering multinational research initiative. This is designed to transform the lives of those suffering from a disfiguring and potentially life threatening parasitic disease. The research team has just secured a grant of eight million Euros from the European & Developing Countries Clinical Trials Partnership...
Dr Laura Moro-Martin, freelance medical writer at Kolabtree, the freelance platform for scientists, explores the effects of COVID-19 on maternal health. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to escalate worldwide, with Europe and the USA now the epicentres of the pandemic. As of May 1, there are over three million declared cases and almost 240,000 deaths globally, with many countries undergoing community transmission....
HALIX B.V. has joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine (ChAdOx1 nCoV-19), being developed by the University’s Jenner Institute. This GMP manufacturing scale-up is taking place alongside early phase clinical trials. The trials are crucial in testing whether the vaccine is proven to be effective....
HORIBA UK Ltd, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help haematology laboratories simplify and expedite the performance of blood and body fluid differentials. CellaVision’s digital cell morphology systems can now be integrated with HORIBA’s HELO automated haematology platform, enabling unique two-way data flow and rapid validation of cell morphology results....
The Lighthouse Laboratory in Glasgow – a major new COVID-19 testing facility based in Scotland – is now operational. The Lighthouse Lab, which officially started testing samples for COVID-19 this week, is part of what will be the biggest network of diagnostic testing facilities in British history, alongside other Lighthouse Lab sites in Milton Keynes and Alderley Park, which were opened in recent days....
The Wyss Institute for Biologically Inspired Engineering at Harvard University and Cytosurge AG, a company manufacturing unique high-precision nanotechnology instruments, have announced that they will collaboratively investigate CRISPR-based approaches to more effectively introduce multiple edits into the genome of single cells, while minimizing CRISPR-related toxicity. This capability could become instrumental in driving forward diverse large-scale efforts such as...
Data scientists from UK-headquartered AI precision medicine company, PrecisionLife, have used the Company’s proprietary AI enabled precision medicine platform to identify 59 repurposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from severe COVID-19. The new study, released on Biorxiv sought to identify genetic risk factors for sepsis especially in the context of COVID-19, and to use these insights to identify existing....
A group of researchers based at Rothamsted Research have responded to a request from the White House, Microsoft, Mark Zuckerberg and others to find a way to rapidly sift through the mountain of COVID-19 scientific data. Taking time off from their own research, the Rothamsted team repurposed a tool they had originally developed to help crop scientists, to provide medical researchers with quick and intuitive access to all documented linkages between genes, medicines, and the virus....
For use in advanced medical research into inflammation, oncology and nephritis the 7T PET-MR imaging system from MR Solutions provides a combination of PET and MRI images either simultaneously or separately. This ground breaking combination technology allows researchers to have superior soft tissue contrast and molecular imaging together.
U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company) Anti-SARS-CoV-2 ELISA (IgG) serology test. Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA for the detection of antibodies of the immunoglobulin class G....
Analysis work from the MRC-University of Glasgow Centre for Virus Research provides evidence that SARS-CoV-2, the virus that causes COVID-19, has not mutated into different types. Recent research had suggested that more than one type of SARS-CoV-2 was now circulating in the pandemic, with one strain being more aggressive and causing more serious illness than the other. Now, using analysis of SARS-CoV-2 virus samples from the pandemic, scientists have been able to show that only one type of the virus is currently circulating....
To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia and industry groups battling the spread of the pandemic globally. Under the program, the company will provide 50 units of the Ion Torrent Genexus System at a subsidized price to support global collaborative COVID-19 research....